| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |